NPPB and hydrops fetalis: The PROVE-HF study reported a significant correlation between the degree of change in LVESVI and the change in NT-proBNP from baseline to follow-up, but this study lack of a control group [14] and was not able to demonstrate a superior effect of ARNI over other RAS inhibitors.